Lu Huang

Lu Huang

Bristol-Myers Squibb Co. - New York / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4386141
-
person_outline Lu Huang's MOST POPULAR ARTICLES
1-) Update of TTD: therapeutic target databaseF Zhu, BC Han, P Kumar, XH Liu, XH Ma, XN Wei, L Huang, YF Guo, ...Nucleic acids research 38 (suppl_1), D787-D791, 20102832010
2-) Combination therapy and the evolution of resistance: the theoretical merits of synergism and antagonism in cancerEC Saputra, L Huang, Y Chen, L Tucker-KelloggCancer research 78 (9), 2419-2431, 2018602018
3-) In vitro iCLIP-based modeling uncovers how the splicing factor U2AF2 relies on regulation by cofactorsFXR Sutandy, S Ebersberger, L Huang, A Busch, M Bach, HS Kang, ...Genome research 28 (5), 699-713, 2018742018
4-) Predicting drug combination index and simulating the network-regulation dynamics by mathematical modeling of drug-targeted EGFR-ERK signaling pathwayL Huang, Y Jiang, Y ChenScientific reports 7 (1), 40752, 2017762017
5-) Virtual populations for quantitative systems pharmacology modelsY Cheng, R Straube, AE Alnaif, L Huang, TA Leil, BJ SchmidtSystems Medicine, 129-179, 2022322022